{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:11:48Z","timestamp":1767139908827,"version":"build-2238731810"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"11-12","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pflugers Arch - Eur J Physiol"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s00424-016-1894-6","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T09:21:11Z","timestamp":1478164871000},"page":"1909-1918","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Counter-flow suggests transport of dantrolene and 5-OH dantrolene by the organic anion transporters 2 (OAT2) and 3 (OAT3)"],"prefix":"10.1007","volume":"468","author":[{"given":"Birgitta C.","family":"Burckhardt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja","family":"Henjakovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohannes","family":"Hagos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Burckhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,3]]},"reference":[{"key":"1894_CR1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ejps.2010.03.023","volume":"40","author":"L Badolo","year":"2010","unstructured":"Badolo L, Rasmussen LM, Hansen HR, Sveigaard C (2010) Screening of OATP1B1\/3 and OCT1 inhibitors in cryopreserved hepatocytes in suspension. Eur J Pharm Sci 40:283\u2013288. doi: 10.1016\/j.ejps.2010.03.023","journal-title":"Eur J Pharm Sci"},{"key":"1894_CR2","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1080\/00498250600861751","volume":"36","author":"K Bleasby","year":"2006","unstructured":"Bleasby K, Castle JC, Roberts CJ, Cheng C, Bailey WJ, Sina JF, Kulkarni AV, Hafey MJ, Evers R, Johnson JM, Ulrich RG, Slatter JG (2006) Expression profiles of 50 xenobiotic transporter genes in human and pre-clinical species: a resource for investigations into drug disposition. Xenobiotica 36:963\u2013988. doi: 10.1080\/00498250600861751","journal-title":"Xenobiotica"},{"key":"1894_CR3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248\u2013254","journal-title":"Anal Biochem"},{"key":"1894_CR4","doi-asserted-by":"publisher","first-page":"F227","DOI":"10.1152\/ajprenal.00113.2016","volume":"311","author":"D Breljak","year":"2016","unstructured":"Breljak D, Ljubojevic M, Hagos Y, Micek V, Balen Eror D, Vrhovac Madunic I, Bzica H, Karaica D, Radovic N, Kraus O, Anzai N, Koepsell H, Burckhardt G, Burckhardt BC, Sabolic I (2016) Distribution of the organic anion transporters NaDC3 and OAT1-3 along the human nephron. Am J Phys 311:F227\u2013F238. doi: 10.1152\/ajprenal.00113.2016","journal-title":"Am J Phys"},{"key":"1894_CR5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/jpharmthera.2012.07.010","volume":"136","author":"G Burckhardt","year":"2012","unstructured":"Burckhardt G (2012) Drug transport by organic anion transporters (OATs). Pharmacol Therapeut 136:106\u2013130. doi: 10.1016\/jpharmthera.2012.07.010","journal-title":"Pharmacol Therapeut"},{"key":"1894_CR6","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1124\/mol.59.5.1277","volume":"59","author":"SH Cha","year":"2001","unstructured":"Cha SH, Sekine T, Fukushima J-I, Kanai Y, Kobayashi Y, Goya T, Endou H (2001) Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Mol Pharmacol 59:1277\u20131286. doi: 10.1124\/mol.59.5.1277","journal-title":"Mol Pharmacol"},{"key":"1894_CR7","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.bcp.2014.11.006","volume":"93","author":"L Cheung","year":"2015","unstructured":"Cheung L, Yu DMT, Neiron Z, Failes TW, Andt GM, Fletcher JI (2015) Identification of new MRP4 inhibitors from a library of FDA approved drugs using a high-throughput bioluminescence screen. Biochem Pharmacol 93:380\u2013388. doi: 10.1016\/j.bcp.2014.11.006","journal-title":"Biochem Pharmacol"},{"key":"1894_CR8","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1124\/mol.107.043117","volume":"73","author":"CD Cropp","year":"2008","unstructured":"Cropp CD, Komori T, Shima JE, Urban TJ, Yee SW, More SS, Giacomini KM (2008) Organic anion transporter 2 (SLC22A7) is a facilitative transporter of cGMP. Mol Pharmacol 73:1151\u20131158. doi: 10.1124\/mol.107.043117","journal-title":"Mol Pharmacol"},{"key":"1894_CR9","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1124\/dmd.107.019257","volume":"36","author":"J Enokizono","year":"2008","unstructured":"Enokizono J, Kusuhara H, Ose A, Schinkel AH, Sugiyama Y (2008) Quantitative investigation of the role of breast cancer resistance protein (Bcrp\/Abcg2) in limiting brain and testis penetration of xenobiotic compounds. Drug Metab Dis 36:995\u20131002. doi: 10.1124\/dmd.107.019257","journal-title":"Drug Metab Dis"},{"key":"1894_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/clpt.2009.236","volume":"9","author":"KM Giacomini","year":"2010","unstructured":"Giacomini KM, Huang S-M, Tweedie DJ et al (2010) Membrane transporters in drug development. Nature Rev Drug Discov 9:215\u2013236. doi: 10.1038\/clpt.2009.236","journal-title":"Nature Rev Drug Discov"},{"key":"1894_CR11","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1124\/jpet.103.059139","volume":"308","author":"H Hasannejad","year":"2004","unstructured":"Hasannejad H, Takeda M, Taki K, Shin HJ, Babu E, Jutabha P, Khamdang S, Aleboyeh M, Onozato ML, Tojo A, Enomoto A, Anzai N, Narikawa S, Huang X-L, Niwa T, Endou H (2004) Interactions of human organic anion transporters with diuretics. J Pharmacol Exp Therapeut 308:1021\u20131029. doi: 10.1124\/jpet.103.059139","journal-title":"J Pharmacol Exp Therapeut"},{"key":"1894_CR12","doi-asserted-by":"publisher","first-page":"F56","DOI":"10.1038\/clpt.2009.236","volume":"304","author":"JN Harper","year":"2013","unstructured":"Harper JN, Wight SH (2013) Multiple mechanisms of ligand interaction with the human organic cation transporter, OCT2. Am J Physiol Renal Physiol 304:F56\u2013F67. doi: 10.1038\/clpt.2009.236","journal-title":"Am J Physiol Renal Physiol"},{"key":"1894_CR13","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3389\/fphys.2015.00420","volume":"6","author":"EO Hernandez-Ochoa","year":"2016","unstructured":"Hernandez-Ochoa EO, Pratt SJP, Lovering RM, Schneider MF (2016) Critical role of intracellular RyR1 calcium release channels in skeletal muscle function and disease. Front Physiol 6:420. doi: 10.3389\/fphys.2015.00420","journal-title":"Front Physiol"},{"key":"1894_CR14","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.3389\/fphys.2015.00420","volume":"35","author":"C Hilgendorf","year":"2007","unstructured":"Hilgendorf C, Ahlin G, Seithel A, Artursson P, Ungell A-L, Karlson J (2007) Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines. Drug Metab Dis 35:1333\u20131340. doi: 10.3389\/fphys.2015.00420","journal-title":"Drug Metab Dis"},{"key":"1894_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1517\/14728214.2015.1018178","volume":"20","author":"KS Just","year":"2015","unstructured":"Just KS, Gerbershagen MU, Grensemann J, Wappler F (2015) Do we foresee new emerging drugs to treat malignant hyperthermia? Expert Opin Emerging Drugs 20:161\u2013164. doi: 10.1517\/14728214.2015.1018178","journal-title":"Expert Opin Emerging Drugs"},{"key":"1894_CR16","doi-asserted-by":"publisher","first-page":"F1026","DOI":"10.1152\/ajprenal.00169.2011","volume":"301","author":"M Kaufhold","year":"2011","unstructured":"Kaufhold M, Schulz K, Breljak D, Gupta S, Henjakovic M, Krick W, Hagos Y, Sabolic I, Burckhardt BC, Burckhardt G (2011) Differential interaction of dicarboxylates with human sodium-dicarboxylate cotransporter 3 and organic anion transporters 1 and 3. Am J Physiol Renal Physiol 301:F1026\u2013F1034. doi: 10.1152\/ajprenal.00169.2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"1894_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1750-1172-9-8","volume":"9","author":"W Klingler","year":"2014","unstructured":"Klingler W, Heiderich S, Girad T, Gravino E, Heffron JJA, Johannsen S, Jurkat-Rott K, R\u00fcffert H, Schuster F, Snoeck M, Sorrentino V, Tegazin V, Lehmann-Horn F (2014) Functional and genetic characterization of clinical malignant hyperthermia crises: a multi-centre study. Orphanet J Rare Dis 9:8. doi: 10.1186\/1750-1172-9-8","journal-title":"Orphanet J Rare Dis"},{"key":"1894_CR18","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/1750-1172-9-8","volume":"59","author":"T Krause","year":"2004","unstructured":"Krause T, Gebershagen MU, Fiege M, Wei\u00dfhorn R, Wappler F (2004) Dantrolene\u2014a review of ist pharmacology, therapeutic use and new developments. Anaesthesia 59:364\u2013373. doi: 10.1186\/1750-1172-9-8","journal-title":"Anaesthesia"},{"key":"1894_CR19","doi-asserted-by":"publisher","DOI":"10.1177\/1352458516643600","author":"S Otero-Romero","year":"2016","unstructured":"Otero-Romero S, Sastre-Garriga J, Comi G, Hartung H-P, Soelberg-Sorensen P, Thompson AJ, Vermersch P, Gold R, Montalban X (2016) Pharmacological management of spasticity in multiple sclerosis: systemic review and consensus paper. Multiple Sclerosis Journal doi. doi: 10.1177\/1352458516643600","journal-title":"Multiple Sclerosis Journal doi"},{"key":"1894_CR20","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1002\/cphy.c100084","volume":"1","author":"RM Pelis","year":"2011","unstructured":"Pelis RM, Wright SH (2011) Renal transport of organic anions and cations. Compr Physiol 1:1795\u20131835. doi: 10.1002\/cphy.c100084","journal-title":"Compr Physiol"},{"key":"1894_CR21","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1002\/cphy.c100084","volume":"101","author":"T Podranski","year":"2005","unstructured":"Podranski T, Bouillon SPM, Taguchi A, Sessler DI, Kurz A (2005) Compartmental pharmacokinetics of dantrolene in adults: do malignant hyperthermia association dosing guidelines work? Anesth Analg 101:1695\u20131699. doi: 10.1002\/cphy.c100084","journal-title":"Anesth Analg"},{"key":"1894_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/cphy.c100084","volume":"10","author":"H Rosenberg","year":"2015","unstructured":"Rosenberg H, Pollock N, Schiemann A, Bulger T, Stowell K (2015) Malignant hyperhermia: a review. Orphanet J Rare Dis 10:93. doi: 10.1002\/cphy.c100084","journal-title":"Orphanet J Rare Dis"},{"key":"1894_CR23","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2147\/TCRM.S47632","volume":"10","author":"D Schneiderbanger","year":"2014","unstructured":"Schneiderbanger D, Johannsen S, Roewer N, Schuster F (2014) Management of malignant hyperthermia: diagnosis and treatment. Therapeut Clin Risk Management 10:355\u2013362. doi: 10.2147\/TCRM.S47632","journal-title":"Therapeut Clin Risk Management"},{"key":"1894_CR24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/B978-0-12-800223-0.00005-0","volume":"73","author":"B Stieger","year":"2014","unstructured":"Stieger B, Hagenbuch B (2014) Organic anion transporting polypeptides. Curr Top Membr 73:205\u2013232. doi: 10.1016\/B978-0-12-800223-0.00005-0","journal-title":"Curr Top Membr"},{"key":"1894_CR25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ejpharm.2003.10.017","volume":"483","author":"M Takeda","year":"2004","unstructured":"Takeda M, Noshiro R, Onozato ML, Tojo A, Hasannejad H, Huang X-L, Narikawa S, Endou H (2004) Evidence for a role of human organic anion transporters in the muscular side effects of HMG-CoA reductase inhibitors. Europ J Pharmacol 483:133\u2013138. doi: 10.1016\/j.ejpharm.2003.10.017","journal-title":"Europ J Pharmacol"},{"key":"1894_CR26","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/jps.2600650618","volume":"65","author":"JJ Vallner","year":"1976","unstructured":"Vallner JJ, Sternson LA, Parsons DL (1976) Interaction of dantrolene sodium with human serum albumin. J Pharmaceut Sci 65:873\u2013877. doi: 10.1002\/jps.2600650618","journal-title":"J Pharmaceut Sci"},{"key":"1894_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/bdd.693","volume":"31","author":"AL VanWert","year":"2010","unstructured":"VanWert AL, Gionfriddo MR, Sweet DH (2010) Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology. Biopharm Drug Dispos 31:1\u201371. doi: 10.1002\/bdd.693","journal-title":"Biopharm Drug Dispos"},{"key":"1894_CR28","unstructured":"www.ryanodex.com\/about\/clinical-pharmacology"}],"updated-by":[{"DOI":"10.1007\/s00424-016-1910-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2016,11,26]],"date-time":"2016-11-26T00:00:00Z","timestamp":1480118400000}}],"container-title":["Pfl\u00fcgers Archiv - European Journal of Physiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-016-1894-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00424-016-1894-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-016-1894-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T22:43:16Z","timestamp":1498344196000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00424-016-1894-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":28,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["1894"],"URL":"https:\/\/doi.org\/10.1007\/s00424-016-1894-6","relation":{},"ISSN":["0031-6768","1432-2013"],"issn-type":[{"value":"0031-6768","type":"print"},{"value":"1432-2013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}